Skip to main content
. 2014 Jun;52(6):1998–2002. doi: 10.1128/JCM.03089-13

TABLE 3.

Overall performance characteristics of Lyra C. difficile assay compared to enhanced toxigenic culturea

Test site Platform No. of results
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
True Pos. True Neg. False Pos. False Neg.
1 Cepheid SmartCycler 20 98 3 4 83.3 (61.8–94.5) 97.0 (90.9–99.2) 87.0 (65.3–96.6) 96.1 (89.7–98.7)
ABI 7500 Fast DX 21 99 2 3 87.5 (66.5–96.7) 98.0 (92.3–99.7) 91.3 (70.5–98.5) 97.1 (91.0–99.2)
ABI Quant Studio DX 20 101 0 4 83.3 (61.8–94.5) 100.0 (95.4–100.0) 100.0 (80.0–100.0) 96.2 (90.0–98.8)
2 Cepheid SmartCycler 24 90 4 2 92.3 (73.4–98.7) 95.7 (88.8–98.6) 85.7 (66.4–95.3) 97.8 (91.6–99.6)
ABI 7500 Fast DX 25 90 4 1 96.2 (78.4–99.8) 95.7 (88.8–98.6) 86.2 (67.4–95.5) 98.9 (93.2–99.9)
ABI Quant Studio DX 24 93 1 2 92.3 (73.4–98.7) 98.9 (93.4–99.9) 96.0 (77.7–99.8) 97.9 (91.9–99.6)
3 Cepheid SmartCycler 48 286 8 14 77.4 (64.7–86.7) 97.3 (94.5–98.7) 85.7 (73.2–93.2) 95.3 (92.1–97.3)
ABI 7500 Fast DX 54 294 0 8 87.1 (75.6–93.9) 100.0 (98.4–100.0) 100.0 (91.7–100.0) 97.4 (94.6–98.8)
ABI Quant Studio DX 52 290 4 10 83.9 (71.9–91.6) 98.6 (96.3–99.6) 92.9 (81.9–97.7) 96.7 (93.8–98.3)
Total Cepheid SmartCycler 92 474 15 20 82.1 (73.5–88.5) 96.9 (94.9–98.2) 86.0 (77.6–91.7) 96.0 (93.7–97.)
ABI 7500 Fast DX 100 483 6 12 89.3 (81.7–94.1) 98.8 (97.2–99.5) 94.3 (87.6–97.7) 97.6 (95.7–98.7)
ABI Quant Studio DX 96 484 5 16 85.7 (77.5–91.4) 99.0 (97.4–99.6) 95.0 (88.3–98.2) 96.8 (94.7–98.1)
a

Pos., positive; Neg., negative; CI, confidence interval.